Steve E. Krognes
2021
In 2021, Steve E. Krognes earned a total compensation of $6.6M as Chief Financial Officer and Treasurer at Denali Therapeutics, a 54% increase compared to previous year.
Compensation breakdown
| Bonus | $300,690 |
|---|---|
| Option Awards | $3,648,420 |
| Salary | $501,150 |
| Stock Awards | $2,125,800 |
| Other | $11,600 |
| Total | $6,587,660 |
Krognes received $3.6M in option awards, accounting for 55% of the total pay in 2021.
Krognes also received $300.7K in bonus, $501.2K in salary, $2.1M in stock awards and $11.6K in other compensation.
Rankings
In 2021, Steve E. Krognes' compensation ranked 1,889th out of 12,415 executives tracked by ExecPay. In other words, Krognes earned more than 84.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,889 out of 12,415 | 85th |
Division Manufacturing | 708 out of 5,505 | 87th |
Major group Chemicals And Allied Products | 266 out of 2,375 | 89th |
Industry group Drugs | 226 out of 2,096 | 89th |
Industry Biological Products, Except Diagnostic Substances | 64 out of 449 | 86th |
Source: SEC filing on April 19, 2022.
Krognes' colleagues
We found three more compensation records of executives who worked with Steve E. Krognes at Denali Therapeutics in 2021.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019